• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Risk for Avian Influenza Virus Exposure at Human?Wildlife Interface

Sally Furniss

Well-known member
Risk for Avian Influenza Virus Exposure at Human?Wildlife Interface

http://www.cdc.gov/eid/content/14/7/pdfs/08-0066.pdfJennifer Siembieda,* Christine K. Johnson,* Walter Boyce,* Christian Sandrock,? and Carol Cardona*

*University of California, Davis, School of Veterinary Medicine, Davis, California, USA; and ?University of California, Davis, School of Medicine, Sacramento, California, USA

To assess risk for human exposure to avian influenza viruses (AIV), we sampled California wild birds and marine mammals during October 2005?August 2007and estimated human?wildlife contact. Waterfowl hunters were 8 times more likely to have contact with AIV-infected wildlife than persons with casual or occupational exposures (p<0.0001).


....Conclusions
We did not detect AIV (H5N1) in California during October 2005?August 2007 nor did other surveillance efforts in the United States (9).

We did detect other AIVs, although at a low prevalence (<1%). The prevalence of AIV in California wildlife was substantially lower than the prevalence reported in Alaskan wildlife in the same flyway (10). AIV prevalence may decrease with latitude (11), or this opportunistic sample design may have resulted in testing of species with a natural low prevalence. Although overall prevalence was low, it was highest in the recreational category and, coupled with the directness and intensity of the contacts especially during bird cleaning, this group would be expected to have the highest risk for infection. However, emergence or introduction of a virus that causes disease in wild birds or animals would likely result in a disproportional shift in prevalence of infection in wildlife brought to rehabilitation hospitals, thus making occupational contact more risky. As a recent example, 1 stork and 2 buzzards that were infected with AIV (H5N1) were brought to a wildlife hospital in Poland, which potentially exposed staff (12).

Novel transmission pathways are possible in places like recovery hospitals because wild species that do not meet in nature are brought into close and extended contact with each other and humans. For example, marine mammals are susceptible to infection with AIV (4) and human influenza viruses (13) and have been documented as intermediate hosts (4). Other species may also be intermediate hosts for AIV, although they have not been identified. Those working in wildlife occupations should be encouraged to wear personal protective equipment when handling wildlife because of the types of contacts they can have and the potential for viruses to emerge in this setting. Similarly, personal protection should be recommended for waterfowl hunters because of the relatively higher prevalence of AIV in the birds with which they have contact.

We assessed the risk for human exposure to AIV by opportunistically sampling wildlife at the human?wild animal interface. A better measure of human risk would be to directly assess human exposure by testing for antibodies to all AIV subtypes that could occur in nature. Although it is not practical to simultaneously test for 144 virus subtypes, 2 serologic studies of persons exposed to wildlife showed antibodies to a limited number of AIVs (3,14). Since these exposures did not cause discernable illness, diagnosis based on clinical signs would likely underestimate infection.

Although our methods enabled us to compare exposure risk among different groups, the testing methods we used likely did not estimate the true AIV prevalence in wildlife. The real-time RT-PCR used in this study and in national surveillance efforts (7) has not been validated in wildlife (10), nor has virus isolation in embryonating chicken eggs, and it may be that neither method is perfect in detecting AIV in species that are only distantly related to chickens (15).

Improved diagnostic methods are needed to assess AIV infections in wildlife species, and close monitoring of persons with the highest level of exposure to AIV is a necessary component of an early warning system to detect transmission from animals to humans.
 
Back
Top